328 related articles for article (PubMed ID: 21412165)
1. Stage IIA1 versus stage IIA2 cervical cancer: does the new staging criteria predict survival?
Garg G; Shah JP; Toy EP; Christensen C; Deppe G; Asaad R; Morris RT
Int J Gynecol Cancer; 2011 May; 21(4):711-6. PubMed ID: 21412165
[TBL] [Abstract][Full Text] [Related]
2. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
[TBL] [Abstract][Full Text] [Related]
3. Survival analysis of Stage IIA1 and IIA2 cervical cancer patients.
Lai JC; Chou YJ; Huang N; Tsai JJ; Huang SM; Yang YC; Chang CL; Wang KL
Taiwan J Obstet Gynecol; 2013 Mar; 52(1):33-8. PubMed ID: 23548215
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
5. Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer.
Chen Y; Zhang L; Tian J; Fu X; Ren X; Hao Q
Int J Gynecol Cancer; 2013 Jan; 23(1):157-63. PubMed ID: 23221732
[TBL] [Abstract][Full Text] [Related]
6. Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system.
Osaku D; Komatsu H; Okawa M; Iida Y; Sato S; Oishi T; Harada T
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1054-1058. PubMed ID: 34794737
[TBL] [Abstract][Full Text] [Related]
7. Oncological Outcomes After Okabayashi-Kobayashi Radical Hysterectomy for Early and Locally Advanced Cervical Cancer.
Sakuragi N; Kato T; Shimada C; Kaneuchi M; Todo Y; Mitamura T; Takeda M; Kudo M; Murakami G; Watari H
JAMA Netw Open; 2020 May; 3(5):e204307. PubMed ID: 32379332
[TBL] [Abstract][Full Text] [Related]
8. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
Bean LM; Ward KK; Plaxe SC; McHale MT
Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
[TBL] [Abstract][Full Text] [Related]
9. Preoperative magnetic resonance imaging criteria for predicting lymph node metastasis in patients with stage IB1-IIA2 cervical cancer.
He F; Zu S; Chen X; Liu J; Yi Y; Yang H; Wang F; Yuan S
Cancer Med; 2021 Aug; 10(16):5429-5436. PubMed ID: 34278729
[TBL] [Abstract][Full Text] [Related]
10. Impact of tumor size on survival in cancer of the cervix and validation of stage IIA1 and IIA2 subdivisions.
Wagner AE; Pappas L; Ghia AJ; Gaffney DK
Gynecol Oncol; 2013 Jun; 129(3):517-21. PubMed ID: 23528928
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy.
Zaganelli FL; Carvalho FM; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
Int J Gynecol Cancer; 2010 Oct; 20(7):1225-31. PubMed ID: 21135594
[TBL] [Abstract][Full Text] [Related]
12. Laparotomic radical hysterectomy versus minimally invasive radical hysterectomy using vaginal colpotomy for the management of stage IB1 to IIA2 cervical cancer: Survival outcomes.
Yang EJ; Kim NR; Lee AJ; Shim SH; Lee SJ
Medicine (Baltimore); 2022 Feb; 101(8):e28911. PubMed ID: 35212297
[TBL] [Abstract][Full Text] [Related]
13. [Trend in proportion and clinicopathological characteristics of young women with stage Ⅰa2 to Ⅱa2 cervical cancer].
Wang W; Hao M; Chen CL; Liu P; Ling B; Kang S; Lu AW; Wang WL; Zhao WD; Zhu QY; Zhao YY; Zhao HW; Jin SL; Ni Y; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):666-672. PubMed ID: 31648442
[No Abstract] [Full Text] [Related]
14. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
15. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of stage IB cervical cancer.
Ungár L; Pálfalvi L; Tarnai L; Nechushkina V; Lintner B; Novák Z;
Int J Gynecol Cancer; 2012 Nov; 22(9):1597-603. PubMed ID: 23051962
[TBL] [Abstract][Full Text] [Related]
17. Can laparoscopic radical hysterectomy be a standard surgical modality in stage IA2-IIA cervical cancer?
Hong JH; Choi JS; Lee JH; Eom JM; Ko JH; Bae JW; Park SH
Gynecol Oncol; 2012 Oct; 127(1):102-6. PubMed ID: 22683586
[TBL] [Abstract][Full Text] [Related]
18. Minimally invasive surgical management of early-stage cervical cancer: an analysis of the risk factors of surgical complications and of oncologic outcomes.
Garabedian C; Merlot B; Bresson L; Tresch E; Narducci F; Leblanc E
Int J Gynecol Cancer; 2015 May; 25(4):714-21. PubMed ID: 25647258
[TBL] [Abstract][Full Text] [Related]
19. Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer.
Canaz E; Ozyurek ES; Erdem B; Aldikactioglu Talmac M; Yildiz Ozaydin I; Akbayir O; Numanoglu C; Ulker V
Int J Gynecol Cancer; 2017 Oct; 27(8):1722-1728. PubMed ID: 28617687
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting parametrial invasion in patients with early-stage cervical carcinomas.
Hsu HC; Tai YJ; Chen YL; Chiang YC; Chen CA; Cheng WF
PLoS One; 2018; 13(10):e0204950. PubMed ID: 30335786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
